NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: BYND 32.83%
Expected US Company Earnings on Wednesday, February 25th, 2026
NASDAQ: CDIO 32.65%
BioMedNewsBreaks - Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) Schedules Investor Conference Call for Feb. 19, 2026
NASDAQ: EDSA 47.03%
$38M Defense Backlog vs. $6M Market Cap, Breakthrough Biotech Data, and the Quantum Security Land Grab
NYSE: BATL 21.08%
Halftime Market Summary: Stocks to Watch before Super Bowl Weekend
NYSE: NGNE 21.95%
NYSE: ACXIF 21.95%
NYSE: BYND 21.95%
NYSE: CDIO 21.95%
NYSE: EDSA 21.95%
